Literature DB >> 6463565

Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein.

J Sander, M K Fagerhol, J S Bakken, I Dale.   

Abstract

Plasma levels of a novel leucocyte protein (L1) were determined in a series of 176 febrile patients and compared with CRP, BLC, and BSR. Among 82 patients with bacterial infection, 81 had L1 levels above the 0.95 interval. Levels of 40 to 130 times the normal mean were seen frequently during life-threatening infections like septicaemia, meningitis, or pneumonia. In contrast, 23 of 27 patients with viral infections had normal L1 levels. A poor correlation was found between L1 levels, CRP, BLC, and BSR, suggesting that these parameters reflect different aspects of the response to tissue damage and inflammation. L1 and CRP seem equal in distinguishing between bacterial and viral infections. Low or normal L1 levels argue strongly against a bacterial infection, while elevated L1 levels discriminate poorly between bacterial and non-infectious inflammatory or malignant diseases.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6463565     DOI: 10.3109/00365518409083820

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  13 in total

1.  MRP 8/14 as marker for Plasmodium falciparum-induced malaria episodes in individuals in a holoendemic area.

Authors:  G Bordmann; G Burmeister; S Saladin; H Urassa; S Mwankyusye; N Weiss; M Tanner
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

2.  Blue mode does not offer any benefit over white light when calculating Lewis score in small-bowel capsule endoscopy.

Authors:  Anastasios Koulaouzidis; Sarah Douglas; John N Plevris
Journal:  World J Gastrointest Endosc       Date:  2012-02-16

3.  Calprotectin as a marker of inflammation in cystic fibrosis.

Authors:  B E Golden; P A Clohessy; G Russell; M K Fagerhol
Journal:  Arch Dis Child       Date:  1996-02       Impact factor: 3.791

Review 4.  Functional and clinical aspects of the myelomonocyte protein calprotectin.

Authors:  B Johne; M K Fagerhol; T Lyberg; H Prydz; P Brandtzaeg; C F Naess-Andresen; I Dale
Journal:  Mol Pathol       Date:  1997-06

5.  Calprotectin expression in vitro by oral epithelial cells confers resistance to infection by Porphyromonas gingivalis.

Authors:  K Nisapakultorn; K F Ross; M C Herzberg
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

6.  Calcium binding and concomitant changes in the structure and heat stability of calprotectin (L1 protein).

Authors:  C F Naess-Andresen; B Egelandsdal; M K Fagerhol
Journal:  Clin Mol Pathol       Date:  1995-10

7.  Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro.

Authors:  G Hetland; G J Talgö; M K Fagerhol
Journal:  Mol Pathol       Date:  1998-06

8.  Regulation of S100A8/A9 (calprotectin) binding to tumor cells by zinc ion and its implication for apoptosis-inducing activity.

Authors:  Yuichi Nakatani; Masatoshi Yamazaki; Walter J Chazin; Satoru Yui
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

Review 9.  The RAGE axis in systemic inflammation, acute lung injury and myocardial dysfunction: an important therapeutic target?

Authors:  Benedict C Creagh-Brown; Gregory J Quinlan; Timothy W Evans; Anne Burke-Gaffney
Journal:  Intensive Care Med       Date:  2010-07-15       Impact factor: 17.440

Review 10.  Calprotectin: An Ignored Biomarker of Neutrophilia in Pediatric Respiratory Diseases.

Authors:  Grigorios Chatziparasidis; Ahmad Kantar
Journal:  Children (Basel)       Date:  2021-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.